Similarly, i.p. treatment of [212Pb]Pb-TCMC-chOI-1 targeting protein tyrosine kinase 7 (PTK7) was evaluated for the treatment of ovarian cancer, showing tumor retention and uptake into the systemic blood circulation after i.p. injection. This evidence concerns the gene PTK7 and ovarian carcinoma.